Trilantic North America inks $945m sale of SOFIE Biosciences to GE HealthCare
Published on October 5, 2026
SOFIE Biosciences runs a US network of 15 contract manufacturing sites operating 21 cyclotrons for PET radiopharmaceuticals.
The post Trilantic North America inks $945m sale of SOFIE Biosciences to GE HealthCare appeared first on PE Hub.
